Venture fund to be extended by two years

Guest Contributor
June 13, 2001

Market conditions have prompted the Health Care & Biotechnology Venture Fund to be extended two years until February 28/04. The closed-end investment trust managed by MDS Capital Corp will divest all of its assets by that date at the latest. The fund has already paid in excess of its paid-in capital to unit holders and its remaining net asset value as of May 18/01 was $31.1 million.


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.